Literature DB >> 28662445

Direct reprogramming with SOX factors: masters of cell fate.

Lisa M Julian1, Angela Ch McDonald2, William L Stanford3.   

Abstract

Over the last decade significant advances have been made toward reprogramming the fate of somatic cells, typically by overexpression of cell lineage-determinant transcription factors. As key regulators of cell fate, the SOX family of transcription factors has emerged as potent drivers of direct somatic cell reprogramming into multiple lineages, in some cases as the sole overexpressed factor. The vast capacity of SOX factors, especially those of the SOXB1, E and F subclasses, to reprogram cell fate is enlightening our understanding of organismal development, cancer and disease, and offers tremendous potential for regenerative medicine and cell-based therapies. Understanding the molecular mechanisms through which SOX factors reprogram cell fate is essential to optimize the development of novel somatic cell transdifferentiation strategies.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28662445     DOI: 10.1016/j.gde.2017.06.005

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  30 in total

1.  SOX11 hypermethylation as a tumor biomarker in endometrial cancer.

Authors:  Tianjiao Shan; Denise S Uyar; Li-Shu Wang; David G Mutch; Tim H-M Huang; Janet S Rader; Xiugui Sheng; Yi-Wen Huang
Journal:  Biochimie       Date:  2019-03-29       Impact factor: 4.079

Review 2.  SOX4: The unappreciated oncogene.

Authors:  Carlos S Moreno
Journal:  Semin Cancer Biol       Date:  2019-08-21       Impact factor: 15.707

3.  H3.3 Barcoding of Nucleus Accumbens Transcriptional Activity Identifies Novel Molecular Cascades Associated with Cocaine Self-administration in Mice.

Authors:  Mathieu E Wimmer; Bruno Fant; Sarah E Swinford-Jackson; Alexander Testino; Duncan Van Nest; Ted Abel; R Christopher Pierce
Journal:  J Neurosci       Date:  2019-05-01       Impact factor: 6.167

Review 4.  Regulation of fibroblast-like synoviocyte transformation by transcription factors in arthritic diseases.

Authors:  Pallavi Bhattaram; Kyle Jones
Journal:  Biochem Pharmacol       Date:  2019-03-13       Impact factor: 5.858

Review 5.  Transcriptional Control of Peripheral Nerve Regeneration.

Authors:  Yunsong Zhang; Qian Zhao; Qianqian Chen; Lingchi Xu; Sheng Yi
Journal:  Mol Neurobiol       Date:  2022-10-20       Impact factor: 5.682

6.  Transcriptional signature primes human oral mucosa for rapid wound healing.

Authors:  Ramiro Iglesias-Bartolome; Akihiko Uchiyama; Alfredo A Molinolo; Loreto Abusleme; Stephen R Brooks; Juan Luis Callejas-Valera; Dean Edwards; Colleen Doci; Marie-Liesse Asselin-Labat; Mark W Onaitis; Niki M Moutsopoulos; J S Gutkind; Maria I Morasso
Journal:  Sci Transl Med       Date:  2018-07-25       Impact factor: 17.956

7.  Analysis of long and short enhancers in melanoma cell states.

Authors:  David Mauduit; Ibrahim Ihsan Taskiran; Liesbeth Minnoye; Maxime de Waegeneer; Valerie Christiaens; Gert Hulselmans; Jonas Demeulemeester; Jasper Wouters; Stein Aerts
Journal:  Elife       Date:  2021-12-07       Impact factor: 8.140

8.  Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer.

Authors:  Yusuke Inoue; Ana Nikolic; Dylan Farnsworth; Rocky Shi; Fraser D Johnson; Alvin Liu; Marc Ladanyi; Romel Somwar; Marco Gallo; William W Lockwood
Journal:  Elife       Date:  2021-06-14       Impact factor: 8.140

Review 9.  Contributions of the Endothelium to Vascular Calcification.

Authors:  Li Zhang; Jiayi Yao; Yucheng Yao; Kristina I Boström
Journal:  Front Cell Dev Biol       Date:  2021-05-17

10.  A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.

Authors:  Hernando Lopez-Bertoni; Ivan S Kotchetkov; Nicole Mihelson; Bachchu Lal; Yuan Rui; Heather Ames; Maria Lugo-Fagundo; Hugo Guerrero-Cazares; Alfredo Quiñones-Hinojosa; Jordan J Green; John Laterra
Journal:  Cancer Res       Date:  2020-02-24       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.